STOCKS SURGE AFTER SOFT U.S. JOBS PRINT, SOLID APPLE RESULTS

Employers add 175,000 jobs in April; unemployment rate unexpectedly jumps to 3.9%

GILD Jan 2025 80.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

1.0600

0.0000

(0.00%)

As of 01:22PM EDT. Market open.

Loading interactive chart...

Zacks
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine are included in this Analyst Blog.
Zacks
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Deciphera Pharmaceuticals, Inc. (DCPH) and GSK are in focus on acquisition news and Q1 earnings, respectively.
Business Wire
Gilead Sciences to Present at Upcoming Investor Conferences
FOSTER CITY, Calif., April 30, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: